Eva Benavent

Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention

Marjan Wouthuyzen‐Bakker, Marine Sebillotte, José Manuel Lomas et al. · Journal of Infection · 2018 · 147 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +16

Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study

Marjan Wouthuyzen‐Bakker, Marine Sebillotte, José Manuel Lomas et al. · Journal of Infection · 2019 · 68 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study

Marjan Wouthuyzen‐Bakker, Marine Sebillotte, Kaisa Huotari et al. · Clinical Orthopaedics and Related Research · 2020 · 59 citations · Full text

Medicine, Infectious Diseases, Orthopedic Surgery +15

Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model

Joan Gómez‐Junyent, Eva Benavent, Yanik Sierra et al. · International Journal of Antimicrobial Agents · 2019 · 52 citations

Life Sciences, Pharmacology, Pharmacotherapy +14

Osteoarticular infection caused by MDR<i>Pseudomonas aeruginosa</i>: the benefits of combination therapy with colistin plus β-lactams

Alba Ribera, Eva Benavent, Jaime Lora-Tamayo et al. · Journal of Antimicrobial Chemotherapy · 2015 · 44 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15